Trial Profile
A retrospective study of raltegravir containing antiretroviral therapy evaluating prevention of mother to child transmission in a high risk population of HIV-infected pregnant women
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Oct 2016
Price :
$35
*
At a glance
- Drugs Raltegravir (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 15 Oct 2016 New trial record